Evidence mapPaperPMID 41141358Full record

ArticleFrontiers in endocrinology2025

Stressed β-cells contribute to loss of peri-islet extracellular matrix in type 1 diabetes.

Chelsea G Johansen, Kenedee Lam, Nikki L Farnsworth

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Chelsea G JohansenDepartment of Chemical and Biological Engineering, Colorado School of Mines, Golden, CO, United States.
Kenedee LamDepartment of Chemical and Biological Engineering, Colorado School of Mines, Golden, CO, United States.
Nikki L FarnsworthDepartment of Chemical and Biological Engineering, Colorado School of Mines, Golden, CO, United States.

Funding

University of Colorado Anschutz Medical Campus DRCP30DK116073 · UNIVERSITY OF COLORADO DENVER · 2025 to 2025
$1.3M
The Role of the Pancreas Microenvironment in Regulating Islet Function and Survival in Type 1 DiabetesR01DK137221 · COLORADO SCHOOL OF MINES · 2025 to 2025
$353k
The role of the peri-islet extracellular matrix in islet function and the pathogenesis of type 1 diabetesF31DK132926 · COLORADO SCHOOL OF MINES · 2025 to 2025
$40k
NIDDK NIH HHS F31 DK132926NIDDK NIH HHS P30 DK116073NIDDK NIH HHS R01 DK137221
6 · The paper itself

Abstract

Introduction: Type 1 diabetes (T1D) is characterized by the immune-mediated destruction of insulin-producing β-cells in pancreatic islets. The peri-islet extracellular matrix (ECM) is a complex protein barrier that is lost in T1D, in part due to infiltrating immune cells. The contribution of stressed β-cells to ECM degradation during T1D remains unclear. Methods: To bridge this gap, we used 12-15-week-old NOD mice and pancreas sections from healthy, ≥2 autoantibody positive (Aab+), and recent onset T1D donors. We focused on MMP-3 due to its role in degrading type IV collagen (COL IV) in the peri-islet ECM. Results: Treatment with proinflammatory cytokines or hyperglycemia increased MMP-3 gene expression and protein levels in mouse and human islets. In NOD pancreas sections, increased MMP-3 expression in β-cells correlates with loss of COL IV during insulitis and hyperglycemia; however, this was independent of insulitis score. We observed similar increases in MMP-3 and loss of COL IV in islets and exocrine tissue from Aab+ and recent onset T1D donors. Conclusion: These results suggest that stressed β-cells degrade the ECM during preclinical T1D, further weakening the peri-islet ECM barrier and facilitating islet infiltration and death. Inhibiting expression of MMP-3 may represent a novel treatment to prevent islet death in T1D.

Indexed as

Diabetes Mellitus, Type 1Extracellular MatrixInsulin-Secreting CellsIslets of LangerhansAnimalsCollagen Type IVFemaleHumansHyperglycemiaMaleMatrix Metalloproteinase 3MiceMice, Inbred NODCollagen Type IVMatrix Metalloproteinase 3cytokinesextracellular matrix (ECM)hyperglycemiaislet beta (β) cellstype 1 diabetes (T1D)

Identifiers

PMID41141358
PMCPMC12549269

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.